Kopran can climb further. Kopran Ltd. is a holding company, which engages in the manufacturing of pharmaceuticals and related products. It operates through the following business units: Formulations, and Active Pharmaceutical Ingredients. The firm's products include Amyn, Lokit, and Ciproquin.
Kopran Ltd CMP is 320. The positive aspects of the company are Company with Low Debt, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding, Annual Profit Growth higher than Sector Profit Growth AND Mutual Funds Increased Shareholding in Past Month. The Negative aspects of the company are Declining Net Cash Flow : Companies not able to generate net cash AND Stocks in the sell zone based on days traded at current PE and P/BV.
Entry can be taken after closing above 321. Targets in the stock will be 330 and 342. The long-term target in the stock will be 352 AND 368. Stop loss in the stock should be maintained at Closing below 291.
Disclaimer: The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
